Delek US (NYSE:DK) Upgraded by Wall Street Zen to Buy Rating

Wall Street Zen upgraded shares of Delek US (NYSE:DK) from a hold rating to a buy rating in a research report sent to investors on Saturday morning.

DK has been the topic of a number of other research reports. Mizuho upped their price target on shares of Delek US from $45.00 to $51.00 and gave the company an “outperform” rating in a research report on Friday, December 12th. Scotiabank set a $34.00 price objective on Delek US in a research report on Friday, January 16th. UBS Group boosted their price objective on Delek US from $31.00 to $42.00 and gave the company a “neutral” rating in a research note on Tuesday, November 18th. Wells Fargo & Company upped their target price on Delek US from $43.00 to $53.00 and gave the company an “overweight” rating in a research report on Monday, November 10th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Delek US in a research note on Wednesday, January 21st. Four investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $39.46.

Delek US Stock Down 5.4%

Shares of NYSE DK opened at $42.35 on Friday. The company’s 50 day moving average price is $32.38 and its 200-day moving average price is $33.38. The company has a debt-to-equity ratio of 5.89, a quick ratio of 0.58 and a current ratio of 0.82. Delek US has a 52-week low of $11.02 and a 52-week high of $45.74. The company has a market capitalization of $2.54 billion, a P/E ratio of -121.00 and a beta of 0.75.

Delek US (NYSE:DK) last posted its quarterly earnings data on Friday, February 27th. The oil and gas company reported $0.44 earnings per share for the quarter, topping the consensus estimate of ($0.19) by $0.63. Delek US had a negative net margin of 0.21% and a negative return on equity of 13.55%. The company had revenue of $2.43 billion during the quarter, compared to analysts’ expectations of $2.55 billion. During the same period in the prior year, the company posted ($2.54) earnings per share. Delek US’s revenue for the quarter was up 2.3% compared to the same quarter last year. Equities analysts forecast that Delek US will post -5.5 earnings per share for the current year.

Delek US Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 9th. Shareholders of record on Monday, March 2nd will be paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date is Monday, March 2nd. Delek US’s payout ratio is -291.43%.

Insider Activity

In other Delek US news, EVP Joseph Israel sold 38,000 shares of the firm’s stock in a transaction on Wednesday, March 4th. The shares were sold at an average price of $40.65, for a total value of $1,544,700.00. Following the transaction, the executive vice president directly owned 55,623 shares of the company’s stock, valued at approximately $2,261,074.95. This trade represents a 40.59% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Reuven Spiegel sold 20,000 shares of Delek US stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $42.84, for a total transaction of $856,800.00. Following the transaction, the executive vice president owned 48,530 shares of the company’s stock, valued at $2,079,025.20. This represents a 29.18% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders have sold 142,764 shares of company stock valued at $5,989,317. 1.80% of the stock is currently owned by insiders.

Institutional Trading of Delek US

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Caitong International Asset Management Co. Ltd raised its stake in shares of Delek US by 95.6% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 884 shares of the oil and gas company’s stock worth $26,000 after purchasing an additional 432 shares during the last quarter. Brown Brothers Harriman & Co. bought a new position in shares of Delek US in the third quarter valued at approximately $27,000. EverSource Wealth Advisors LLC boosted its position in shares of Delek US by 173.4% during the fourth quarter. EverSource Wealth Advisors LLC now owns 968 shares of the oil and gas company’s stock valued at $29,000 after buying an additional 614 shares during the last quarter. AlphaQuest LLC grew its holdings in Delek US by 7,331.8% during the second quarter. AlphaQuest LLC now owns 1,635 shares of the oil and gas company’s stock worth $35,000 after buying an additional 1,613 shares in the last quarter. Finally, Torren Management LLC bought a new stake in Delek US during the fourth quarter worth $40,000. 97.01% of the stock is owned by institutional investors.

Key Delek US News

Here are the key news stories impacting Delek US this week:

• Positive Sentiment: TD Cowen raised its price target from $28 to $44 (hold), narrowing upside uncertainty and signaling improving analyst visibility. Finviz
• Positive Sentiment: Quarterly results: Delek US reported a surprise EPS beat ($0.44 vs. est. -$0.19), which is supportive for the shares despite a slight revenue shortfall. (Source: company/market coverage)
• Positive Sentiment: Dividend declared: a $0.255 quarterly dividend (annualized $1.02, ~2.3% yield) payable March 9 — offers short-term income support for the stock.
• Neutral Sentiment: Institutional activity: several large funds have adjusted positions recently (mix of increases and new stakes); institutional ownership remains high (~97%), which can both stabilize and concentrate stock moves.
• Negative Sentiment: CEO sale: CEO Avigal Soreq sold 50,000 shares (~$2.05M at ~$41.08). Large insider sales from the CEO often trigger investor concern about timing and outlook. CEO Sale — SEC filing: Form 4
• Negative Sentiment: Additional insider selling: multiple executives and directors sold sizable stakes in early March (EVPs Reuven Spiegel — 20,000 sh; Joseph Israel — 38,000 sh; Directors Shlomo Zohar and William Finnerty also sold). The cluster of senior-level sales is adding downward pressure. Relevant SEC filings: Spiegel (Read More.), Israel (Read More.), Zohar (Read More.), Finnerty (Read More.).
• Negative Sentiment: Analyst moves mixed-to-negative: Citi and Piper Sandler trimmed price targets (to $33 and $40 respectively) and Weiss reiterated a sell — these downward revisions amplify selling pressure even as some shops (e.g., Mizuho) remain bullish.

Delek US Company Profile

Delek US Holdings, Inc (NYSE: DK) is an independent downstream energy company engaged in the refining, logistics, and marketing of petroleum products. Headquartered in Brentwood, Tennessee, the company operates a network of inland refineries, storage terminals and pipelines, and convenience store locations. Delek US focuses on converting crude oil into a variety of finished products, including gasoline, diesel, jet fuel, asphalt and renewable fuels, serving wholesale and retail customers across the United States.

In its refining segment, Delek US owns and operates four inland refineries located in Texas and Arkansas.